| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Longest survival with primary intracranial malignant melanoma: A case report and literature review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tang-Fai Wong, Yin-Sheng Chen, Xiang-Heng Zhang, Wan-Ming Hu, Xiao-Shi Zhang, Yan-Chun Lv, Dong-Cun Huang, Mei-Ling Deng and Zhong-Ping Chen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zhong-Ping Chen, MD, PhD, Chief Doctor, Neurosurgeon, Professor, Department of Neurosurgery/Neuro-Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, No. 651 Dongfeng East Road, Yuexiu District, Guangzhou 510060, Guangdong Province, China. chenzhp@sysucc.org.cn |
| Key Words |
Primary intracranial malignant melanoma; Immunotherapy; Newcastle disease virus-modified tumor vaccine; β-elemene; Long-term survival; Case report |
| Core Tip |
PIMM is quite rare, and its prognosis is poor. Comprehensive treatment, including the surgical resection and the maintenance of postoperative adjuvant treatments by NDV-modified tumor vaccine, Interferon and β-Elemene may prolong patient survival. We hope that the PIMM case reported in this paper, which describes a patient whose life was extended by 22 years, can provide useful information for the reference of medical practitioners and patients alike, thereby boosting their confidence in adopting the treatment reported herein. |
| Publish Date |
2022-10-21 02:24 |
| Citation |
Wong TF, Chen YS, Zhang XH, Hu WM, Zhang XS, Lv YC, Huang DC, Deng ML, Chen ZP. Longest survival with primary intracranial malignant melanoma: A case report and literature review. World J Clin Cases 2022; 10(30): 11162-11171 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i30/11162.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i30.11162 |
